Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)

Not Applicable

Completed

• Conditions: Reproductive Techniques, Assisted
• Interventions: Drug: Acetyl Salicylic Acid and Terbutalin

• Registration Number: NCT00518141
• Lead Sponsor: Sykehuset Telemark

Brief Summary

This study aims to determine the possible effects of Acetyl Salicylic Acid (ASA) and Terbutalin on ART treatment.

Detailed Description

This study aims to determine the possible effects of ASA and Terbutalin on ART treatment.

Study Timeline

• Study Start: 2006-03
• Study First Submitted: 2007-08-17
• Study First Submitted QC: 2007-08-17
• Study First Posted: 2007-08-20
• Primary Completion: 2009-05
• Study Completion: 2009-05
• Status Verified: 2011-07
• Last Update Submitted: 2011-07-20
• Last Update Posted: 2011-07-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

• Infertile women below 39 years of age

Exclusion Criteria

• Women who may react allergically to the drugs administered
• Women with hyperthyroid or IDDM
• Women who do not want to participate in the study
• Women who are unable to give informed, written consent.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
3	Acetyl Salicylic Acid and Terbutalin	SET
5	Acetyl Salicylic Acid and Terbutalin	DET
1	Acetyl Salicylic Acid and Terbutalin	FER

Primary Outcome Measures

Name	Time	Method
Pregnancy	7 weeks

Trial Locations

Locations (1)

STHF, Kvinneklinikken, Fertilitetsklinikken Sor; 🇳🇴 Porsgrunn, Telemark, Norway